Autism: Pharmaceutical Trials and Advancements

Recent advances within the genetic science of autism underlines its etiological heterogeneousness, with every genetic susceptibility locus accounting for a small fraction of cases or having little result. Several of the year’s most significant advances used new technologies to review and engineered on the muse and pilgrim of information established by years of investment in basic analysis. The paths and advancements in autism research aided in constructing hope and sensible can for the treatment of the drugs.

To present a paper on pharmaceutical trials and advancements, submit the abstract here. Email confirmation of the submitted abstract will be sent upon successful acceptance of the abstract

 

  • clinical trails of autism
  • Advanced diagnosis of autistic genome sequence
  • Early intervention program in autism
  • Hyperbaric oxygen treatment
  • Improvising the autistic disorders

Related Conference of Autism: Pharmaceutical Trials and Advancements

March 18-19, 2024

34th Euro Congress on Psychiatrists and Psychologists

Zurich, Switzerland
April 11-12, 2024

4th Annual Congress on Mental Health

Amsterdam, Netherlands
May 23-24, 2024

41th Global Psychiatry and Mental Health Conference

Zurich, Switzerland
May 27-28, 2024

6th European Autism Congress

Paris, France
July 15-16, 2024

6th International Congress on Mental Health

Amsterdam, Netherlands
September 09-10, 2024

5th Annual Congress on Psychiatry

London, UK

Autism: Pharmaceutical Trials and Advancements Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in